NCT00482638View on ClinicalTrials.gov

Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

May 12, 2004

Primary Completion Date

October 29, 2004

Study Completion Date

October 29, 2004

Conditions

Obesity

Interventions

DRUG

MK0493

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00482638 - Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED) | Biotech Hunter | Biotech Hunter